PTX 2.44% 4.2¢ prescient therapeutics limited

Ann: CSO named among Top 20 Translational Researchers by Nature, page-7

  1. 1,656 Posts.
    lightbulb Created with Sketch. 198
    I concur with previous poster, advantages with this biotech company include; current usa funding of phase two clinical trials, patient specific targetting, very low volume of shares (including proposed dilution), and great management/ceo team.., disadvantages run the full spectrum as other aus bios, but in particular to ptx is money in the bank. So, the tip was/is good imo yet with some luck and patience, reward will follow.., hope that helps cheers
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.